Bactine Antiseptic Spray Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Johnson & Johnson is the best-performing bactine antiseptic spray brand in July 2026, moving 40,000 units across 1 ASIN for 23.8% of Top 10 volume. Neosporin follows with 40,000 units (23.8%), ahead of Bactine MAX on 20,000 units (11.9%).

Volume is spread across 10 brands, with the top three holding 59.5% between them. No single label controls the shelf, which usually leaves room for a well-differentiated listing to take share without outspending an incumbent. Average selling prices among the leaders run from $4.88 to $8.97, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B09WSTBRBN booked 9K units at $5.97, with ▲ 0.0% MoM change. On the growth side, B0DVNXH4W3 leads positive momentum with ▲ 100.0% MoM growth on 2K units, with B0GMK4X5SR close behind at ▲ 100.0% MoM on 2K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.